PLOS ONE

December 18, 2023

Study examines social factors and cardiovascular disease risk

Eight social factors were among the top 15 markers of cardiovascular disease risk and could help guide community prevention efforts, according to a new study using machine learning algorithms.

By Paul Govern
July 19, 2023

Study highlights consequences of chronic benzodiazepine use

The lived experience of colleagues who took benzodiazepines and experienced distressing effects inspired a recent study that found the depressant is linked to nervous system injury and negative life effects during and after use.

By Danny Bonvissuto
July 13, 2023

Female health care workers more likely to leave profession during pandemic: HERO registry study

Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

By Leigh MacMillan
November 17, 2022

Study supports removing race from estimate of kidney function

An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.

By Leigh MacMillan
Team members involved in the study include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD. (photo by Jessica Kimber)
August 27, 2021

Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.

By Jill Clendening
November 16, 2020

Imaging “biomarker” for Alzheimer’s disease progression

Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.

By Bill Snyder
September 17, 2020

HIV prevention medication not being prescribed routinely: study

Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.
By Jake Lowary
March 19, 2020

Race, hormones and diabetes risk

Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.
By VUMC News and Communications
July 30, 2019

Intestinal immune cell interactions

Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases.
By Leigh MacMillan
July 16, 2019

A critical factor for wound healing

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.
By Anivarya Kumar
April 11, 2019

Pathways of radiosensitization

Austin Kirschner and colleagues demonstrate how a hormone therapy for prostate cancer improves radiation’s tumor-killing power.
By Leigh MacMillan
April 11, 2019

The arrestin-GPCR connection

Understanding details of how arrestins deactivate signaling by G-protein coupled receptors is key to the design of new therapeutics aimed at these cellular "inboxes" that are targeted by up to half of all pharmaceuticals.
By Sanjay Mishra
October 11, 2018

Community-driven health efforts saving lives in Lwala

Eleven years after two Vanderbilt University medical students established a health care organization in an impoverished area of Kenya, the death rate for children under 5 years old has been cut in half, according to researchers from Kenya and the Vanderbilt Institute for Global Health (VIGH).
By Bill Snyder
1 2 3 … 5